Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Rolf Engstad is active.

Publication


Featured researches published by Rolf Engstad.


Fish & Shellfish Immunology | 1992

Yeast glucan induces increase in lysozyme and complement-mediated haemolytic activity in Atlantic salmon blood.

Rolf Engstad; Børre Robertsen; Erling Frivold

The activities of lysozyme, alkaline and acid phosphatase, N-acetyl-glucosaminidase and complement (as spontaneous haemolytic activity) were measured in plasma of Atlantic salmon, Salmo salar L., after intraperitoneal injection of a β -1,3 and β -1,6 linked glucan from Saccharomyces cerevisiae . The glucan has previously been shown to induce resistance of Atlantic salmon to several bacterial pathogens. The glucan treatment resulted in increased activities of lysozyme 1–3 weeks and complement 2–4 weeks after injection. The activities of alkaline phosphatase and N-acetyl-glucosaminidase showed a decrease 1 week after injection and then slowly restored to normal levels, whereas acid phosphatase was only slightly altered during the experimental period. These results indicate that the glucan induces a selective increase in lysozyme rather than a general release of lysosomal enzymes. The time intervals of enhanced activities of lysozyme and complement partially overlapped with the time intervals of expected enhanced protection against pathogens. Thus, induction of increased activities of lysozyme and complement may, at least in part, explain the mechanisms by which glucan induces protection against bacterial pathogens in salmon.


Developmental and Comparative Immunology | 1993

Recognition of yeast cell wall glucan by Atlantic salmon (Salmo salar L. ) macrophages.

Rolf Engstad; B∅rre Robertsen

Phagocytosis of yeast (Saccharomyces cerevisiae) glucan particles by Atlantic salmon (Salmo salar L.) pronephric macrophages was studied. The particles contained > 95% glucose linked through beta-1,3- and beta-1,6-glycosidic linkages. The macrophages rapidly phagocytized both native and opsonized glucan particles although the latter were taken up at a higher rate. Within 30 min, 40-60% of the macrophages had taken up > 1 native glucan particle. The uptake of native glucan particles could be inhibited by preincubating the macrophages with laminarin, a soluble beta-1,3-linked glucan, and a soluble yeast glucan made by partial formolysis of glucan particles. Soluble yeast glucan, on the other hand, did not inhibit uptake of serum opsonized glucan particles or sheep red blood cells, which showed that it did not interfere with phagocytosis in general or inhibit phagocytosis through complement receptors. Polyglucoses with glycosidic linkages other than beta-1,3, like dextran, glycogen, and pustulan or the polymannose mannan, showed little or no inhibition of phagocytosis of native glucan particles. Altogether these observations indicate that Atlantic salmon macrophages may have a specific receptor for yeast glucan. Studies with chelator- and heat-treated salmon serum showed that glucan particles were opsonized primarily by activation of the alternative complement pathway. However, the data indicate that serum components other than complement may also be involved in the opsonization of glucan particles.


Developmental and Comparative Immunology | 1994

Specificity of a β-glucan receptor on macrophages from Atlantic salmon (Salmo salar L.)

Rolf Engstad; Børre Robertsen

Abstract This study was undertaken to study the specificity of a β-glucan receptor on Atlantic salmon macrophages. Previous in vitro studies have shown that Atlantic salmon macrophages express a receptor that rapidly recognizes and mediates uptake of nonopsonized β-glucan particles. The ingestion of particles was shown to be inhibited by preincubating the macrophages with glucans containing β-1,3-linkages, but not by glucans containing other linkages. In the present study we have shown that small oligomers from formolyzed β-glucan particles, and linear β-1,3-linked oligomers with a degree of polymerization (DP) ⩾ 3, were efficient inhibitors of uptake of glucan particles. Oligomers from β-1,6-linked pustulan, or small size oligomers with linkages other than β-1,3, were not able to inhibit uptake of glucan particles. The inhibitory effect of laminarin and laminariheptaose was abolished by degrading the nonreducing terminal ends by sodium periodate treatment. The inhibitory effect of laminarin was regained by a complete Smith degradation; that is, periodate oxidation followed by reduction and hydrolysis. Modification of the reducing end of laminariheptaose had no effect on its ability to inhibit uptake. Furthermore, it was shown that periodate-oxidized glucan particles were not taken up by salmon macrophages, and that the uptake was regained when the particles were hydrolyzed to recover the nonreducing terminal end. Lastly, it was shown that endo-β-1,6-glucanase treatment of the yeast glucan particles did not reduce uptake, confirming that β-1,6-linkages are not involved in the recognition. These results suggest that Atlantic salmon macrophages possess a receptor that may recognize even very short β-1,3-linked glucosyl chains extending from yeast cell walls.


Fish & Shellfish Immunology | 2001

Enhanced lysozyme production in Atlantic salmon (Salmo salar L.) macrophages treated with yeast β-glucan and bacterial lipopolysaccharide

Steinar M. Paulsen; Rolf Engstad; Børre Robertsen


Fish & Shellfish Immunology | 2003

In vivo effects of β-glucan and LPS on regulation of lysozyme activity and mRNA expression in Atlantic salmon (Salmo salar L.)

Steinar M. Paulsen; Halvor Lunde; Rolf Engstad; Børre Robertsen


Archive | 1995

Enzyme treatment of glucans

Rolf Engstad; Finn Kortner; Børre Robertsen; Gunnar Rorstad


Archive | 2007

Method or use of a solubilized glucan product to increase immunostimulation in animals

Rolf Engstad; Finn Kortner; Børre Robertsen; Gunnar Rorstad


Archive | 2008

Use of glucan for manufacturing immune-stimulating composition and use of glucan as medicine

Rolf Engstad; Finn Kortner; Børre Robertsen; Gunnar Rorstad; エングスタッド,ロルフ; コルトナー,フィン; ロベルトセン,ボレ; ロルスタッド,ギュンナー


Archive | 1996

Glucans enzyme treatment

Rolf Engstad; Finn Kortner; Børre Robertsen; Gunnar Rorstad


Archive | 1995

Traitement enzymatique des glycannnes

Rolf Engstad; Finn Kortner; Børre Robertsen; Gunnar Rorstad

Collaboration


Dive into the Rolf Engstad's collaboration.

Top Co-Authors

Avatar

Børre Robertsen

Norwegian College of Fishery Science

View shared research outputs
Top Co-Authors

Avatar

Gunnar Rorstad

Norwegian College of Fishery Science

View shared research outputs
Top Co-Authors

Avatar

Steinar M. Paulsen

Norwegian College of Fishery Science

View shared research outputs
Top Co-Authors

Avatar

B∅rre Robertsen

Norwegian College of Fishery Science

View shared research outputs
Top Co-Authors

Avatar

Erling Frivold

Norwegian College of Fishery Science

View shared research outputs
Top Co-Authors

Avatar

Halvor Lunde

Norwegian College of Fishery Science

View shared research outputs
Researchain Logo
Decentralizing Knowledge